trospium chloride extended release / Generic mfg. - LARVOL DELTA

Trends in Medicare Coverage of Overactive Bladder Medications in the United States. (PubMed, Urogynecology (Phila)) - "Beta-3 agonists had worse coverage across insurers nationwide. Current trends in Medicare coverage reveal a need for improved coverage of preferred OAB medications for an aging population already at risk of cognitive dysfunction."

Journal • Medicare • Reimbursement • US reimbursement • Cognitive Disorders • Overactive Bladder

A Comparison of U.S. Individual and Family Plan Medication Coverage for Overactive Bladder. (PubMed, Urogynecology (Phila)) - "Despite risks with anticholinergics, beta-3 agonists were more expensive across all insurers highlighting the need for expanded coverage of preferred medications to avoid cognitive dysfunction when undergoing treatment for OAB."

Journal • Cognitive Disorders • Overactive Bladder